Toward a robust computational screening strategy for identifying glycosaminoglycan sequences that display high specificity for target proteins

Glycobiology

Volumn 24, Issue 12, 2014, Pages 1323-1333

  Sankaranarayanan, Nehru Viji ^a   Desai, Umesh R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Glycosaminoglycans; Heparin heparan sulfate; Molecular docking; Specificity; Virtual screening

Indexed keywords

ANTITHROMBIN; DISACCHARIDE; GLYCOSAMINOGLYCAN; HEPARIN; THROMBIN; PROTEIN;

ARTICLE; CARBOHYDRATE ANALYSIS; COMBINATORIAL LIBRARY; COMBINATORIAL VIRTUAL LIBRARY SCREENING; GENE SEQUENCE; GENETIC ALGORITHM; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN TARGETING; ALGORITHM; BIOLOGY; CHEMISTRY; CONFORMATION; ENZYME SPECIFICITY; METABOLISM; MOLECULAR GENETICS;

ALGORITHMS; CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; COMPUTATIONAL BIOLOGY; GLYCOSAMINOGLYCANS; MOLECULAR SEQUENCE DATA; PROTEINS; SUBSTRATE SPECIFICITY;

EID: 84964698250     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwu077     Document Type: Article

References (33)

1. Agostino M, Gandhi NS, Mancera RL. 2014. Development and application of site mapping methods for the design of glycosaminoglycans. Glycobiology (in press).
2. Belzar KJ, Dafforn TR, Petitou M, Carrell RW, Huntington JA. 2000. The effect of a reducing-end extension on pentasaccharide binding by antithrombin. J Biol Chem. 275:8733-8741.
3. Bitomsky W, Wade RC. 1999. Docking of glycosaminoglycans to heparinbinding proteins: Validation for aFGF, bFGF, and antithrombin and application to IL-8. J Am Chem Soc. 121:3004-3013.
4. Capila I, Linhardt RJ. 2002. Heparin-protein interactions. Angew Chem Int Ed. 41:391-412.
5. Carter WJ, Cama E, Huntington JA. 2005. Crystal structure of thrombin bound to heparin. J Biol Chem. 280:2745-2749.
6. Copeland R, Balasubramaniam A, Tiwari V, Zhang F, Bridges A, Linhardt RJ, Shukla D, Liu J. 2008. Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1. Biochemistry. 47: 5774-5783.
7. Cremer D, Pople JA. 1975. A general definition of ring puckering. J Am Chem Soc. 97:1354-1358.
8. Desai UR. 2005. Antithrombin activation and designing novel heparin mimics. In: Garg HG, Linhardt RJ, Hales CA, editors. Chemistry and Biology of Heparin and Heparan Sulfate. Amsterdam: Elsevier Science. p. 483-512.
9. Desai UR. 2013. The promise of sulfated synthetic small molecules as modulators of glycosaminoglycan function. Future Med Chem. 5:1363-1366.
10. Desai UR, Petitou M, Bjork I, Olson ST. 1998. Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin. J Biol Chem. 273:7478-7487.
11. Esko JD, Selleck SB. 2002. Order out of chaos: Assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem. 71:435-471.
12. Forster MJ, Mulloy B. 1993. Molecular dynamics study of iduronate ring conformations. Biopolymers. 33:575-588.
13. Gandhi NS, Mancera RL. 2008. The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des. 72:455-482.
14. Grootenhuis PDJ, van Boeckel CAA. 1991. Constructing a molecular model of the interaction between antithrombin III and a potent heparin analogue. J Am Chem Soc. 113:2743-2747.
15. Guerrini M, Elli S, Mourier P, Rudd TR, Gaudesi D, Casu B, Boudier C, Torri G, Viskov C. 2013. An unusual antithrombin-binding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequence. Biochem J. 449:343-351.
16. Jin L, Abrahams JP, Skinner R, Petitou M, Pike RN, Carrell RW. 1997. The anticoagulant activation of antithrombin by heparin. Proc Natl Acad Sci USA. 94:14683-14688.
17. Johnson DJ, Li W, Adams TE, Huntington JA. 2006. Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation. EMBO J. 25:2029-2037.
18. Jones G, Willett P, Glen RC, Leach AR, Taylor R. 1997. Development and validation of a genetic algorithm for flexible docking. J Mol Biol. 267:727-748.
19. Kirschner KN, Yongye AB, Tschampel SM, Gonzalez-Outeirino J, Daniels CR, Foley BL, Woods RJ. 2008. GLYCAM06: A generalizable biomolecular force field. Carbohydrates. J Comput Chem. 29:622-655.
20. Kitchen DB, Decornez H, Furr JR, Bajorath J. 2004. Docking and scoring in virtual screening for drug discovery: Methods and applications. Nat Rev Drug Disc. 3:935-949.
21. Li W, Johnson DJ, Esmon CT, Huntington JA. 2004. Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat Struct Mol Biol. 11:857-862.
22. Maimone MM, Tollefsen DM. 1990. Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity. J Biol Chem. 265:18263-18271.
23. McCoy AJ, Pei XY, Skinner R, Abrahams JP, Carrell RW. 2003. Structure of beta-antithrombin and the effect of glycosylation on antithrombin's heparin affinity and activity. J Mol Biol. 326:823-833.
24. Mosier PD, Krishnasamy C, Kellogg GE, Desai UR. 2012. On the specificity of heparin/heparan sulfate binding to proteins. Anion-binding sites on antithrombin and thrombin are fundamentally different. PLoS ONE. 7:e48632.
25. Mulloy B, Forster MJ. 2000. Conformation and dynamics of heparin and heparan sulfate. Glycobiology. 10:1147-1156.
26. Olson ST, Halvorson HR, Björk I. 1991. Quantitative characterization of the thrombin-heparin interaction. Discrimination between specific and nonspecific binding models. J Biol Chem. 266:6342-6352.
27. Petitou M, Barzu T, Herault JP, Herbert JM. 1997. A unique trisaccharide sequence in heparin mediates the early step of antithrombin III activation. Glycobiology. 7:323-327.
28. Pike RN, Buckle AM, le Bonniec BF, Church FC. 2005. Control of the coagulation system by serpins. Getting by with a little help from glycosaminoglycans. FEBS J. 272:4842-4851.
29. Pol-Fachin L, Verli H. 2008. Depiction of the forces participating in the 2-O-sulfo-alpha-L-iduronic acid conformational preference in heparin sequences in aqueous solutions. Carbohydr Res. 343:1435-1445.
30. Raghuraman A, Mosier PD, Desai UR. 2006. Finding a needle in a haystack: Development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s). J Med Chem. 49: 3553-3562.
31. Raghuraman A, Mosier PD, Desai UR. 2010. Understanding dermatan sulfateheparin cofactor II interaction through virtual library screening. ACS Med Chem Lett. 1:281-285.
32. Shriver Z, Capila I, Venkataraman G, Sasisekharan R. 2012. Heparin and heparan sulfate: Analyzing structure and microheterogeneity. Handb Exp Pharmacol. 207:159-176.
33. Wallace AC, Laskowski RA, Thornton JM. 1995. LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8:127-134.